» Articles » PMID: 26400380

Antiretroviral Treatment Among Co-infected Tuberculosis Patients in Integrated and Non-integrated Facilities

Overview
Date 2015 Sep 25
PMID 26400380
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: South Africa has the second worst tuberculosis-human immunodeficiency virus (TB-HIV) syndemic in the world: in 2011, the TB-HIV co-infection rate was estimated at 65%. Integration of TB and HIV health-care services was implemented to increase antiretroviral treatment (ART) uptake among eligible patients.

Aim: To evaluate whether integrated TB and HIV facilities had better ART uptake among eligible patients compared to non-integrated facilities.

Methods: A cross-sectional study using routine TB programme data from January to December 2010. ART eligibility was defined as a CD4+ cell count <350 cells/μl.

Results: Respectively 2761 (86.8%) and 3611 (84.7%) patients were eligible for ART at integrated and non-integrated facilities (P < 0.001). The proportion of patients started on ART at integrated facilities did not differ significantly from that of non-integrated facilities (35.9% vs. 37.1%, P = 0.340), but the proportion with unknown HIV status (31.8% vs. 24.5%, P < 0.001) and unknown CD4+ cell count (40.9% vs. 30.4%, P < 0.001) did.

Conclusion: Integration of TB and HIV services in the Free State (2009-2010) was not associated with improved ART uptake. The reasons why are not clear. Of concern are the high proportions of unknown HIV status and CD4+ cell count results, especially at integrated facilities, and the small proportion of patients on ART, which may indicate poor implementation of integration.

Citing Articles

Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.

Burnett S, Zawedde-Muyanja S, Hermans S, Weaver M, Colebunders R, Manabe Y J Acquir Immune Defic Syndr. 2018; 79(5):605-611.

PMID: 30383587 PMC: 6422342. DOI: 10.1097/QAI.0000000000001862.


The patient costs of care for those with TB and HIV: a cross-sectional study from South Africa.

Mudzengi D, Sweeney S, Hippner P, Kufa T, Fielding K, Grant A Health Policy Plan. 2017; 32(suppl_4):iv48-iv56.

PMID: 28204500 PMC: 5886108. DOI: 10.1093/heapol/czw183.

References
1.
Kaplan R, Caldwell J, Bekker L, Jennings K, Lombard C, Enarson D . Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa. S Afr Med J. 2014; 104(3):204-9. DOI: 10.7196/samj.7696. View

2.
Sylla L, Bruce R, Kamarulzaman A, Altice F . Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007; 18(4):306-12. PMC: 2696234. DOI: 10.1016/j.drugpo.2007.03.001. View

3.
Rieder H, Cauthen G, Comstock G, Snider Jr D . Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989; 11:79-98. DOI: 10.1093/oxfordjournals.epirev.a036046. View

4.
Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M . Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health. 2004; 9(6):A11-5. DOI: 10.1111/j.1365-3156.2004.01259.x. View

5.
Abdool Karim S, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A . Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011; 365(16):1492-501. PMC: 3233684. DOI: 10.1056/NEJMoa1014181. View